Current progress in CAR‑T cell therapy for tumor treatment (Review)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current progress in CAR‑T cell therapy for tumor treatment (Review)

Published:2022-08-25 Issue:4 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Chen Lei¹,Xie Ting²,Wei Bing³,Di Da-Lin³

Affiliation:

1. Department of Hematology, Affiliated Hospital of Weifang Medical University, P.R. China

2. School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261031, P.R. China

3. Department of Immunology, Weifang Medical University, Weifang, Shandong 261053, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference94 articles.

1. Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020;Cao;Chin Med J (Engl),2021

2. Recent advances in the treatment of acute lymphoblastic leukemia;Rafei;Leuk Lymphoma,2019

3. Clinical utilization of chimeric antigen receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European society for blood and marrow transplantation (EBMT) and the American society for blood and marrow transplantation (ASBMT);Kansagra;Bone Marrow Transplant,2019

4. Recent advances and discoveries in the mechanisms and functions of CAR T cells;Larson;Nat Rev Cancer,2021

5. CAR-T cell therapy and infection: A review;Bupha-Intr;Expert Rev Anti Infect Ther,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies;Cell Chemical Biology;2024-08

2. Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy;Journal of Materials Chemistry B;2024

3. Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer;International Immunopharmacology;2023-12

4. Epigenetic and Genetic Keys to Fight HPV-Related Cancers;Cancers;2023-11-25

5. RIPTACs: A groundbreaking approach to drug discovery;Drug Discovery Today;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3